Biotech VC Funds

Robert Bosch Venture Capital GmbH (RBVC), founded in 2007, is the corporate venture capital arm of the Bosch Group. Based in Stuttgart-Weilimdorf, Germany, RBVC focuses on investing in innovative technology startups globally, covering early to late-stage investments. Their investment strategy spans multiple sectors, including automation, electrification, mobility solutions, healthcare, energy efficiency, artificial intelligence (AI), Internet of Things (IoT), and advanced computing technologies. RBVC has a diversified portfolio with notable investments in companies such as Aleph Alpha, an AI startup, and AnyClip, a multimedia and design software company. They have also invested in startups like Graphcore, which develops intelligent processing units for AI workloads, and IOTA, which focuses on blockchain-based M2M payments​. The firm typically invests between €3-5 million in initial financing rounds, with the potential to invest up to €15 million in total per company. Additionally, RBVC selectively provides seed capital and participates in other venture capital funds to build a robust international and industrial network​. RBVC's investments have led to several successful exits, including the acquisitions of companies like Foghorn by Johnson Controls and GreenPeak by Qorvo. They are known for leveraging Bosch's extensive network to help startups scale and establish new business models, often fostering co-innovation through the Open Bosch Program.

ROBO Global is an innovative investment firm that focuses on disruptive technologies in robotics, automation, artificial intelligence, and healthcare technology. Founded with a vision to capture the rapid advancements in these sectors, ROBO Global has developed a series of indexes that offer investors diversified exposure to the cutting-edge companies driving these technological transformations. The firm is based in Dallas, Texas, and operates globally, providing a comprehensive framework for investing in the future of technology. ROBO Global’s approach is rooted in deep industry research and collaboration with a network of financial professionals, PhDs, and global industry leaders. Their indexes, such as the ROBO Global Robotics & Automation Index and the ROBO Global Healthcare Technology & Innovation Index, are designed to track the performance of companies leading innovation across these high-growth areas. In 2023, ROBO Global launched its first venture capital fund, ROBO Global Venture Fund I, which focuses on early-stage investments in companies within its core sectors. The fund targets promising startups in information technology, robotics, AI, machine learning, and healthcare, helping to drive the next wave of innovation. ROBO Global’s commitment to capturing the full potential of technological disruption has made it a key player in the investment landscape for those looking to engage with the future of industry and innovation.

The Roche Venture Fund is the corporate venture capital arm of Roche, a global leader in healthcare and pharmaceuticals. With an evergreen fund of CHF 750 million, the fund focuses on investing in life sciences, particularly in pharmaceuticals, diagnostics, and digital health sectors. The fund’s mission is to foster innovation and build commercially successful companies while generating financial returns for Roche. They typically make Series A investments, with initial checks ranging from CHF 5-10 million and a 15-20% equity stake. Roche Venture Fund is active globally, with offices in Basel, Switzerland, and South San Francisco, USA, providing access to a wide network of industry experts and strategic guidance to portfolio companies. Notable investments include companies like Freenome, Black Diamond Therapeutics, and Syapse, which are leaders in fields like diagnostics and precision medicine. The fund offers more than just financial backing, involving themselves deeply in the growth and development of their portfolio companies. This hands-on approach ensures startups benefit from Roche’s vast resources and expertise in navigating the complexities of the life sciences market. Their long-term vision and commitment to innovation make them a preferred partner for biotech and healthtech startups looking to make a significant impact.

Rock Health Capital is a prominent venture capital firm based in San Francisco, focusing on investments in early-stage companies at the intersection of healthcare and technology. Founded in 2010, Rock Health aims to make healthcare more accessible and effective by supporting entrepreneurs with innovative solutions that address critical health challenges. The firm invests in a variety of sectors within digital health, including clinics/outpatient services, healthcare services, AI, analytics, and cloud infrastructure. Their portfolio includes companies like Omada Health, Doctor On Demand, and Evidation Health, reflecting their commitment to transformative healthcare solutions. Rock Health Capital offers more than just funding; they provide strategic guidance, market insights, and a robust network of healthcare professionals and corporate partners. This support helps startups navigate the complex healthcare landscape and scale their innovations effectively. Key team members include Bill Evans, Founder and General Partner, and Tom Cassels, CEO, who bring extensive experience and expertise in healthcare and technology.

Rockport Capital is a distinguished multi-stage venture capital firm with a focus on alternative energy, mobility, and sustainability. They invest in a variety of sectors, partnering with entrepreneurs to foster growth in both industrial and consumer-facing companies. Notable investments in their portfolio include Enphase Energy, Honest Buildings, and Qnovo. These investments highlight Rockport’s commitment to innovative solutions in energy management, real estate technology, and consumer electronics. The firm primarily targets companies within the United States, with a significant presence in California and Massachusetts. Their strategy is characterized by a collaborative approach, leveraging deep domain expertise to support startups from early to growth stages. On average, Rockport invests around $20 million per round, participating actively in about four rounds annually, with a particular emphasis on Series A and B investments. Rockport’s leadership team includes experienced professionals like Managing Partners Bill Geary and Chuck McDermott, who bring extensive industry knowledge and investment acumen to the table. The firm’s founders and partners are deeply involved in guiding and mentoring portfolio companies, ensuring a hands-on approach to venture investing. For startups seeking to connect with Rockport, it is beneficial to present a clear value proposition that aligns with their focus on sustainability and technological innovation. The firm values partnerships with entrepreneurs who are passionate about making a significant impact in their respective industries​.

Rockstart, founded in 2011, is a prominent early-stage investor and domain-focused accelerator based in Amsterdam, with additional offices in Copenhagen and Bogotá. The firm is dedicated to empowering purpose-driven founders by providing fast-track scaling solutions, domain-specific mentorship, and access to a vast network of investors, partners, and experts. Rockstart's investment strategy covers three main domains: Energy, AgriFood, and Emerging Technologies. They support startups from the pre-seed to Series B stages, offering not only capital but also structured guidance and extensive networking opportunities. Their notable investments include startups like Sympower, which secured €22 million to advance Europe's energy transition, and other successful exits like Wercker, acquired by Oracle, and 3D Hubs, acquired for $330 million. The firm's Energy fund, which recently closed at €27 million, focuses on startups driving the energy transition towards renewable, clean, and low-carbon solutions. Rockstart’s AgriFood fund and Emerging Tech fund also support innovative solutions in their respective fields, contributing to a sustainable future. Rockstart's comprehensive accelerator programs are designed to boost collaboration between startups and corporates, facilitating co-creation, commercial partnerships, and investment. Their commitment to supporting the UN Sustainable Development Goals underscores their focus on creating positive global impact through technology and innovation​.

Romulus Capital, founded in 2008, is an early-stage venture capital firm focused on seed and Series A investments. Based in Boston, the firm primarily invests in B2B companies leveraging disruptive technologies in sectors such as artificial intelligence, robotics, and big data. Romulus targets industries that are ripe for transformation, including healthcare, construction, and financial services, often supporting companies emerging from top research universities. Notable investments include Cogito, a customer service AI platform, Reconstruct, which provides AI-powered solutions for construction management, and ClassPass, a leading marketplace for fitness classes. The firm typically invests in companies with deep technology roots, aiming to lead rounds with checks ranging from $100k to $5M, and maintains a long-term commitment to supporting its portfolio through multiple stages of growth. Romulus is known for taking a hands-on approach, helping entrepreneurs navigate challenges beyond capital by offering strategic guidance and leveraging their strong network in the tech ecosystem. They have participated in 68 investments, with 8 successful exits. The firm emphasizes building long-lasting companies, often working closely with founding teams from the early stages of their journey.

Root Ventures, founded in 2013 by Avidan Ross, is a San Francisco-based seed-stage venture capital firm that focuses on deep tech investments. The firm prides itself on supporting technical teams tackling complex engineering challenges. Notable investments include Particle, Shaper, Skycatch, and Plethora, reflecting their commitment to hardware, robotics, and software for physical industries. Root Ventures typically leads seed rounds with investments ranging from $1M to $2M. Their strategy involves not only providing capital but also offering extensive engineering and startup resources, such as roadmap assessments and talent recruiting. The firm’s team, which includes partners Chrissy Meyer, Kane Hsieh, and Lee Edwards, all have strong engineering backgrounds, ensuring they stay closely connected to the technical challenges their portfolio companies face. The fund's unique culture, influenced by Ross's own passion for engineering and building things, emphasizes a maker mindset. This approach helps Root Ventures attract and support startups that aim to democratize toolsets and create innovative solutions in traditionally regulated industries. Startups looking to approach Root Ventures should be prepared to demonstrate a strong technical foundation and a clear vision for solving significant engineering problems. The firm's hands-on approach and technical expertise make them an ideal partner for early-stage companies looking to make a substantial impact.

Rough Draft Ventures is a student-led venture capital initiative powered by General Catalyst, aimed at supporting tech-focused university entrepreneurs. Since its inception, RDV has facilitated the growth of startups that have collectively raised over $2 billion from top investors like Andreessen Horowitz and Sequoia. RDV typically invests $5,000 to $25,000 in early-stage startups, focusing on those with passionate founders and a minimum viable product (MVP). Their notable investments include companies such as Beepi and Reverie Labs. The firm’s geographic focus spans major innovation hubs across the U.S., especially in Boston and California. The investment strategy at RDV is heavily founder-centric, seeking out student entrepreneurs with a compelling "why" behind their ventures and the determination to bring their visions to life. RDV is renowned for its supportive approach, offering not just financial backing but also mentorship, strategic guidance, and community events. Student fellows play a crucial role in RDV, sourcing and vetting investment opportunities. This process ensures that each startup aligns with RDV's values and mission. Key figures like Jeremy Levine from General Catalyst provide essential guidance, fostering a collaborative environment designed to empower student founders and build the next generation of impactful tech startups. This mentorship-driven model helps RDV maintain a robust pipeline of innovative companies while supporting the personal and professional growth of its fellows.

Route 66 Ventures is a private investment firm headquartered in Alexandria, Virginia, focused on backing innovative startups in the financial technology and digital health sectors. Established in 2012, the firm provides both venture capital and credit solutions to early and growth-stage companies. Route 66 Ventures is committed to fostering positive change by supporting businesses that address significant challenges in areas like financial services, health, and wellness. The firm's portfolio includes companies like Affirm, Greenlight, and CircleUp, which are reshaping the financial services landscape. Their investment approach is characterized by flexibility, with initial investments ranging from $500K to $4M, depending on the stage and specific needs of the company. They emphasize working with companies that drive long-term shifts in behavior, regulation, and technology, particularly in industries such as digital health, where they focus on preventive care, wellness, and data-driven health outcomes. Route 66 Ventures also takes pride in its operational expertise, as its team is composed of former operators and business founders. This allows them to offer not only financial backing but also strategic advice and guidance to help companies scale successfully. With a focus on high-growth, innovative companies, Route 66 Ventures continues to support transformative solutions that aim to make a lasting impact on the world​.

RRE Ventures is a well-established VC firm known for its investments in transformative sectors such as AI, fintech, and crypto. Notable portfolio companies include Palantir, Bowery Farming, and Brightwheel, each exemplifying RRE's knack for backing innovative startups. With a particular focus on industries like artificial intelligence, blockchain, and climate tech, RRE actively supports startups working on vertical solutions or platforms that address large-scale challenges. Geographically, RRE is New York-based but operates globally, funding ventures with scalable potential. The firm typically leads rounds and engages early, often at the seed or Series A stages, writing checks around $2M to $10M. Startups looking to work with RRE should highlight strong technical teams and scalable solutions, as the firm seeks data-driven approaches with clear paths to market leadership. Key figures include Will Porteous, who is instrumental in climate and consumer tech investments, and Raju Rishi, focusing on enterprise solutions. Founders are encouraged to approach RRE with well-prepared pitches that demonstrate both market understanding and a clear competitive edge.

RTA Ventures is an early-stage venture capital firm with a strong focus on healthcare-related technologies, including SaaS (Software as a Service) and marketplace business models. Founded by Piotr Kulesza and Lubomir Jurczak, the firm operates out of Berlin, Germany, and Warsaw, Poland. RTA Ventures is particularly known for backing startups that are developing innovative solutions in areas such as health diagnostics, AI, and biotechnology. The firm typically invests in early-stage companies across Europe and the U.S., supporting them with financial backing and strategic guidance. Notable portfolio companies include DocPlanner, a prominent health-tech platform, and MNM Diagnostics, which focuses on applying AI and biotechnology to precision health diagnostics. RTA Ventures generally participates in seed and Series A rounds, often co-investing with other venture funds like Piton Capital and Point Nine Capital. RTA Ventures’ investment philosophy revolves around identifying scalable technologies that address significant needs in healthcare, and they take a hands-on approach, helping startups grow through their early, critical phases. Their average investment size ranges between $1 million and $5 million per deal, and they remain actively involved in their portfolio companies to ensure their success in both domestic and international markets.

RTP Global is a venture capital firm that focuses on early-stage investments in technology-driven companies. Founded in 2000 by Leonid Boguslavsky, RTP Global has a long history of backing ambitious founders building disruptive companies. The firm has invested in over 90 companies, including prominent names like Datadog, Delivery Hero, and Cred. RTP Global operates across North America, Europe, and Asia, with offices in key markets like New York, London, Paris, and Bangalore. Their strategy is centered around providing long-term support to founders from Seed through Series B stages. RTP is known for its fast decision-making process, driven by a lean, globally connected team. The firm also stands out for reinvesting the proceeds from past successes into new ventures, aligning their interests closely with the founders they back. This approach enables RTP to stay involved for the long haul, supporting their portfolio companies through both highs and challenges. The sectors they target include B2B SaaS, fintech, AI, e-commerce, health tech, and more. Their $1 billion Fund IV continues RTP’s legacy of betting on transformational companies and supporting them throughout their entire lifecycle.

Ruffena Capital is a London-based boutique corporate finance advisory firm established in 2013, specializing in raising growth capital and providing financial advisory services. The firm caters to mid-market businesses across various sectors, including digital transformation, life sciences, health tech, consumer goods, and cleantech. With a strong presence in both the UK and Amsterdam, Ruffena Capital works closely with management teams to navigate complex financial markets, offering expertise in securing funding from institutional investors, family offices, and private lenders. Ruffena Capital provides a range of services, including raising new capital, advising on trade finance, arranging secondary share sales, and facilitating LP funding. The firm is known for its ability to secure funding ranging from £2 million to £25 million, focusing on businesses with scalable models and strong growth potential. The firm's advisory services are supported by a team with over 200 years of combined experience in corporate finance and commercial strategy. Operating under the regulatory framework of the Ashberg multifamily office, Ruffena Capital has built a reputation for delivering results through quality, integrity, and a deep understanding of its clients' needs. The firm’s approach is highly personalized, working with a select number of businesses each year to ensure they receive the focused attention required to achieve their financial goals.

Runa Capital is a global venture capital firm established in 2010, known for its focus on early-stage software startups, particularly in deep tech, enterprise software, and fintech infrastructure. With over $500 million in assets under management, Runa Capital invests in companies across 14 countries, including the United States, Germany, and France. The firm typically invests between $1 million and $10 million per company, spanning from seed to Series B stages. Notable investments by Runa Capital include Nginx, an open-source software company acquired by F5 Networks for $670 million, and MariaDB, a leading open-source database management system. The firm has also invested in startups like Capptain (acquired by Microsoft), Ecwid, and Zopa, showcasing its diverse portfolio across various technology sectors. Runa Capital has offices in key global tech hubs including Silicon Valley, London, Berlin, Paris, and Luxembourg, which enables them to support startups with strategic insights and a robust transcontinental network. Their investments are aimed at fostering innovation and helping startups scale in both domestic and international markets.

S28 Capital, based in San Francisco, is a venture capital firm founded in 2015 by Kent Ho and Lyon Wong. The firm specializes in early-stage investments, focusing on seed and Series A rounds in sectors like business products, business services, healthcare, and information technology. S28 Capital is known for supporting startups that disrupt traditional industries with innovative technology solutions​. The firm has a diverse portfolio, with notable investments in companies such as Carbon Robotics, Tenzo, and Lightup Data. S28 Capital has seen significant exits including Kespry, CodeStream, and Cambridge Quantum Computing, highlighting their success in identifying high-potential startups. S28 Capital typically invests in companies across the United States, Europe, and Asia. They are known for their hands-on approach, providing not just financial support but also strategic guidance, leveraging their extensive experience as operators and entrepreneurs. The team includes General Partners Kent Ho and Shvetank Jain, alongside Operating Partners Justin Wong and Victor Pang, and Venture Partner Andrew Miklas​. Startups interested in partnering with S28 Capital can expect a committed and experienced team ready to support their growth through all stages of development. The firm values strong, mission-driven founders and aims to build long-term, impactful relationships with their portfolio companies.

S2G Ventures is a pioneering multi-stage investment firm committed to driving systemic change across food, agriculture, oceans, and clean energy sectors. Their diverse portfolio includes over 70 innovative companies, ranging from seed stage startups to public market giants. Notable investments include Beyond Meat, Sweetgreen, and MycoTechnology, reflecting their dedication to sustainable and impactful business models. S2G Ventures focuses on industries that advance human and environmental health. They target companies in food production, agricultural technology, renewable energy, and ocean sustainability. Geographically, their investments span five continents, showcasing a global reach and influence. Their strategy involves a deep understanding of value chains and second-order thinking, ensuring that investments lead to meaningful, long-term impacts. With $2 billion in assets under management, S2G provides not just capital, but also extensive industry expertise and resources to help companies scale and succeed. Typically, S2G Ventures leads funding rounds with an average check size of $2-20 million, demonstrating a flexible approach to supporting various growth stages. They have been particularly active recently, emphasizing the importance of tailored capital solutions and innovative financial structures, such as debt and hybrid instruments, through their Special Opportunities strategy. The leadership team is spearheaded by Managing Partners Sanjeev Krishnan and Chuck Templeton, who bring decades of experience in multi-asset investing and entrepreneurial support. Their expertise and commitment to systemic change drive S2G's mission to create a healthier and more sustainable world.

S3 Ventures is the largest venture capital firm focused on Texas, based in Austin. Founded in 2005 by Brian R. Smith, S3 Ventures has raised over $900 million across seven funds. The firm primarily invests in early-stage companies, ranging from seed to Series B rounds, with initial investments between $500,000 and $10 million and the potential to invest over $20 million throughout a company's lifecycle​ (S3 Ventures)​​ (S3 Ventures)​. S3 Ventures focuses on three main sectors: business technology, digital experiences, and healthcare technology. They aim to back entrepreneurs who are reimagining how the world works, lives, and heals. Some notable investments include Alkami Technology, Favor Delivery, and TVA Medical​. The firm's unique structure is supported by a single philanthropic limited partner, allowing S3 Ventures to provide patient and flexible capital without the typical fundraising distractions faced by traditional VC firms. This model helps them dedicate more resources and time to their portfolio companies, contributing to the success of startups like Alkami Technology and Acessa Health. The team at S3 Ventures includes experienced professionals like General Partner Charlie Plauche and Venture Partner Eric Engineer, who bring diverse backgrounds in investment banking, technology, and entrepreneurship to the firm.

SaaS Ventures is a Maryland-based venture capital firm that specializes in early-stage investments in B2B SaaS companies. Founded in 2017, SaaS Ventures focuses on supporting visionary SaaS founders at the earliest stages of their business, as well as leveraging unused pro-rata rights to invest alongside proven winners at later stages. The firm recently closed its second fund, raising $20 million to continue investing in promising SaaS startups. SaaS Ventures typically invests between $100,000 and $5 million, with a sweet spot around $1.5 million per investment. Their portfolio includes notable companies like WhiteFox Defense Technologies and Courier. Collin Gutman, a Managing Partner, leads the firm from Miami Beach, Florida. He is supported by a team that includes Dan Eidell, Seth Shuldiner, and Rodd Macklin, all of whom bring extensive experience in venture capital and startup operations. SaaS Ventures is dedicated to not only providing capital but also helping companies scale by offering strategic guidance and connecting them with other quality investors to complete their financing rounds.

BStartup is Banco Sabadell’s venture capital arm, dedicated to supporting startups at various stages of development, from seed to scale-up. Since its inception, BStartup has been instrumental in providing not only financial support but also strategic guidance to help startups grow and thrive. They focus on early-stage digital and technology companies with strong growth potential and innovative business models. BStartup offers equity investments of €100,000 per project, targeting more than ten companies annually across diverse sectors. They have specialized verticals such as BStartup Health, aimed at biotech and medtech companies, and BStartup Green, which focuses on sustainability, energy transition, and smart cities. For more advanced stages, Banco Sabadell can provide follow-on investments through Sabadell Venture Capital, with investments up to €2 million per company. The firm provides startups with access to Banco Sabadell’s extensive network, strategic support in financing processes, and additional benefits from partnerships like Amazon Web Services. They have dedicated offices in major cities like Madrid, Barcelona, and Valencia, ensuring tailored support for startup clients.

Safar Partners is a dynamic venture capital firm based in Cambridge, Massachusetts, specializing in early to growth-stage investments. Founded in 2019, Safar Partners focuses on groundbreaking sectors such as cleantech, advanced materials, AI, robotics, and life sciences, primarily targeting innovations emerging from MIT, Harvard, and the University of Rochester. The firm’s notable investments include Commonwealth Fusion Systems, Agility Robotics, and RightHand Robotics, which highlight their commitment to transformative technologies. Safar Partners has also supported Verve Motion and Quaise Energy, showcasing a diverse portfolio that spans across AI, clean energy, and robotics. Led by Nader Motamedy and Arunas Chesonis, Safar Partners boasts a team of experts with extensive backgrounds in technology and finance. Their strategic approach emphasizes long-term partnerships with founders, leveraging their robust network and deep industry knowledge to drive growth and innovation. Safar Partners typically participates in significant funding rounds, with investments averaging around $12.6 million. They often co-invest with other leading firms like Alumni Ventures and Lowercarbon Capital, further enhancing their investment strategy through collaborative efforts. For startups seeking investment, Safar Partners values clear alignment with their focus areas and appreciates introductions through their established network. Their proactive and supportive approach makes them a sought-after partner for innovative companies aiming to scale rapidly​.

Safran Group, headquartered in Paris, is a leading international high-technology group operating in the aviation, defense, and space markets. With over 92,000 employees and sales of 23.2 billion euros in 2023, Safran is dedicated to contributing to a safer, more sustainable world through its innovative technologies and solutions. One of Safran's most notable projects is its involvement in the development of the LEAP engine through its joint venture with General Electric, CFM International. The LEAP engine is renowned for its efficiency and lower emissions, playing a crucial role in modernizing aircraft propulsion systems. Safran also collaborates with Airbus in the ArianeGroup, focusing on advanced propulsion technologies for civil and military space launch systems, including the Ariane 6 launch vehicle, which aims to enhance Europe's access to space. In the realm of sustainable aviation, Safran is committed to decarbonizing the aerospace industry. They are actively working on projects like the HyPERION initiative, a joint research effort with Airbus and ArianeGroup to develop hydrogen propulsion solutions as a viable alternative to fossil fuels in aviation. Safran’s innovation efforts are also evident in their work on the James Webb Space Telescope, where they provided critical components for the telescope's successful deployment and operation. Additionally, Safran continues to drive advancements in aircraft interiors, landing systems, and avionics, ensuring enhanced safety and comfort for air travel. Through its various subsidiaries and joint ventures, Safran remains at the forefront of technological innovation, striving to meet the evolving needs of the aerospace and defense industries while prioritizing sustainability and environmental responsibility.

Sagana is a global impact investment and advisory firm headquartered in Wollerau, Switzerland. Founded in 2017 by Raya Papp and Wolfgang Hafenmayer, Sagana focuses on driving sustainable change by investing in businesses that address major global challenges, such as climate change, healthcare, and education. Their mission is to align outstanding financial returns with significant positive social and environmental impact. Sagana invests across sectors like climate tech, sustainable fashion, healthcare, and plastic alternatives. Their portfolio includes companies like ACE Green, a platform for sustainable battery recycling; Colorifix, which uses zero toxic chemicals in textile dyeing; and Energy Dome, pioneering long-duration energy storage for grid decarbonization. They also back companies focused on healthcare solutions, such as InHeart, which provides digital twin technology for cardiac arrhythmia treatment, and Homage, a platform connecting trained care providers to the elderly across Asia. Sagana combines its investment strategy with deep sector expertise, helping companies scale effectively while ensuring they deliver impactful solutions. They actively work with portfolio companies through board seats and direct partnerships, fostering growth and maximizing both financial and impact outcomes.

Sailing Capital, founded in 2012 and headquartered in Hong Kong, is a private equity and venture capital firm with a focus on cross-border investments. The firm primarily invests in sectors such as healthcare, technology, consumer retail, and industrials. With a strong presence in China and internationally, Sailing Capital is known for backing innovative, high-growth companies across various stages, from late-stage venture to pre-IPO. Some of their notable portfolio companies include SenseTime, a leader in artificial intelligence and computer vision, and WeRide, a pioneer in autonomous driving technology. Sailing Capital has also invested in NeuroXess, a therapeutic device startup, and DMAI, which focuses on AI-driven healthcare and education solutions. Their investment strategy often includes co-investing alongside major players like Sequoia Capital and IDG Capital, particularly in China and the U.S. The firm is led by CEO Liang Tsui, with a team of experienced partners, including Catherine Fan and Ray Zhang, who bring extensive expertise in international finance and private equity. Sailing Capital's approach combines financial backing with strategic guidance, helping portfolio companies expand globally while leveraging cross-border opportunities​.

Salesforce Ventures, the corporate venture capital arm of Salesforce, has been actively investing in enterprise software companies since its founding in 2009. With headquarters in San Francisco, California, Salesforce Ventures has made over 890 investments across a variety of industries, emphasizing enterprise technology and cloud-based solutions​​. Notable investments include companies like Airtable, Databricks, DocuSign, Guild Education, monday.com, Snowflake, Snyk, Stripe, and Zoom. These investments highlight Salesforce Ventures' focus on backing innovative startups that transform how businesses operate and connect with their customers​​. Salesforce Ventures operates a structured investment approach, including the Salesforce Ventures Impact Fund, which supports companies driving social and environmental impact. This fund has invested in companies such as Arcadia, Rheaply, and Circulor, contributing significantly to climate tech and other critical sectors​​. The firm supports its portfolio companies with resources beyond capital, including strategic guidance, access to Salesforce's vast network, and operational support to help them scale. Key team members like John Somorjai, Khushboo Patel, and Paul Drews lead these efforts, ensuring that the companies they back can leverage Salesforce’s extensive ecosystem to grow and succeed​. For entrepreneurs, an investment from Salesforce Ventures signals strong confidence and provides substantial backing to build companies that can make a significant impact on the global market.

Salesforce, a global leader in customer relationship management, leverages its platform to help businesses connect with customers in new and innovative ways. Notable projects and investments reflect Salesforce's commitment to technological advancement and social impact. Salesforce Ventures, the company's investment arm, has supported over 400 companies since 2009, including high-profile startups like Airtable, Databricks, DocuSign, and Zoom. These investments span various sectors such as AI, cloud computing, and enterprise software, aligning with Salesforce's strategic goals of driving innovation and digital transformation. In terms of notable projects, Salesforce is investing heavily in AI and sustainability. The company recently opened its first AI research center in London, part of a $4 billion investment in AI innovation in the UK. This center focuses on developing cutting-edge AI technologies to enhance Salesforce's offerings and drive forward the next generation of AI-driven CRM solutions. Salesforce's Impact Fund, managed by Salesforce Ventures, invests in companies creating social and environmental impact. Focus areas include education, workforce development, climate, diversity, and digital health. Noteworthy investments from this fund include companies like Guild Education, which improves access to education and career opportunities, and WeaveGrid, which supports the transition to electric vehicles and clean energy. Salesforce's commitment to customer success is exemplified through various case studies. For instance, Heathrow Airport increased digital revenue by 30% through personalized marketing strategies powered by Salesforce, and General Mills tripled consumer engagement using data analytics and AI to tailor their marketing campaigns.

Sand Hill Angels, based in Silicon Valley, is a prominent angel investment group known for backing innovative startups across various industries. Their portfolio includes notable companies like Sweetgreen, Vaxart, and Archer, highlighting their commitment to disruptive solutions and defensible technologies. They have a strong focus on sectors such as information technology, healthcare, and consumer products, reflecting their diverse investment strategy​​. Geographically, Sand Hill Angels primarily invests in startups based in the United States, particularly within the Bay Area. They engage in early-stage to B-stage investments, providing not only capital but also mentorship and strategic guidance from their 140+ members, who are experienced entrepreneurs and business leaders​. The average investment size ranges from $1 million to $5 million, with a typical focus on companies with strong teams and clear go-to-market plans. They are known for being active co-investors and often collaborate with other venture capital funds to support the growth of their portfolio companies​​. Key team members include successful technology professionals and angel investors dedicated to fostering the growth of startup companies. For entrepreneurs looking to connect with Sand Hill Angels, it’s beneficial to emphasize innovative, scalable business models and a well-defined market problem​​. In summary, Sand Hill Angels is a vital player in the angel investing landscape, leveraging its members' expertise to nurture and accelerate the growth of high-potential startups.

Sandbox Industries is a Chicago-based venture capital firm, founded in 2003, that focuses on driving innovation in critical sectors like healthcare, insurance, and food & agriculture. The firm is known for managing the Blue Venture Funds in partnership with Blue Cross Blue Shield, targeting early-stage investments in healthcare technology and services. These funds have supported the growth of companies like Livongo and Lumeris, helping them achieve significant market impact. Sandbox also operates the Cultivian Sandbox Food & Ag Fund, investing in sustainable agricultural technologies, efficient food distribution, and innovative consumer products. This aligns with their mission to foster transformative change in industries that shape human livelihoods. Sandbox combines traditional venture capital with corporate investment strategies, partnering with industry leaders to create unique ecosystems that support their portfolio companies. The firm has made over 200 investments, positioning itself as a major player in both healthcare and agtech innovation.

Sands Capital is a global investment firm with over $50 billion in assets under management, specializing in high-growth public and private companies. Founded in 1992 and headquartered in Arlington, Virginia, Sands Capital operates with a singular focus on identifying and investing in businesses that have the potential for long-term exponential growth. The firm’s investment strategies span across public equity, venture capital, and private growth equity, targeting companies that drive innovation and create transformative change across industries. Sands Capital follows a highly concentrated, high-conviction approach, focusing on a select few companies that meet its stringent investment criteria. This approach enables the firm to build deep relationships with portfolio companies and provide them with long-term support. Some of the firm's notable investments include Nubank, Anduril Industries, and Kaspi, all of which are leaders in their respective sectors, ranging from fintech to defense technology. The firm emphasizes a collaborative culture and long-term thinking, encouraging its team of over 60 investment professionals to develop deep domain expertise. With offices in the U.S., London, and Singapore, Sands Capital seeks to capitalize on global opportunities while fostering innovation that addresses large-scale, structural changes in various industries. Through its growth-focused investment strategies, Sands Capital aims to generate significant value for its clients over time.

Sanofi Ventures is the corporate venture capital arm of Sanofi, focusing on early-stage biotech and digital health companies that align with Sanofi's strategic areas of interest. Founded in 2001 and headquartered in Cambridge, Massachusetts, the fund actively invests in fields like immunology, oncology, rare diseases, cell and gene therapy, and digital health. With over 105 investments, the firm partners with companies that are developing breakthrough therapies and technologies aimed at transforming healthcare. Sanofi Ventures plays a hands-on role in its portfolio, often leading rounds from seed to Series B and beyond. What sets it apart from traditional VCs is the added access to Sanofi's deep expertise in clinical development, regulatory pathways, and commercialization strategies. This allows its portfolio companies to scale efficiently and navigate complex healthcare markets. Notable portfolio companies include Nura Bio (focused on neuroprotective therapies), Carbon Health (a modern healthcare provider), and Granite Bio (targeting autoimmune and inflammatory diseases). Sanofi Ventures also seeks to foster long-term partnerships, aiming to accelerate growth while preparing companies for potential acquisition or further financing opportunities​.

Santé Ventures, based in Austin, Texas, is a leading venture capital firm specializing in early-stage investments within the healthcare and life sciences sectors. Since its founding in 2006, the firm has raised over $800 million across multiple funds and primarily focuses on biotech, medtech, and healthtech companies that aim to deliver better patient outcomes at lower costs. Their strategy is to identify and support groundbreaking innovations in biology, medicine, and healthcare technologies, often leading or co-leading seed and Series A funding rounds. Santé has built a reputation for being an active investor, frequently becoming the first institutional backer of startups or even helping to create new companies from scratch. The firm’s portfolio includes high-impact companies like Molecular Templates, Claret Medical, and AbVitro, which have seen successful exits through acquisitions by major healthcare players like Boston Scientific, Celgene, and IBM. Their ability to spot potential early has led to a strong track record of performance, marked by 76 investments and 13 notable exits. In 2021, Santé raised $260 million for its fourth fund, which is focused on supporting 15-25 companies in the biotech, medtech, and healthtech sectors. With offices in both Austin and Boston, Santé continues to leverage its deep expertise in healthcare to identify transformative technologies that can reshape the industry and improve patient lives on a global scale. The firm’s disciplined approach ensures consistent returns, making it a key player in the life sciences venture capital ecosystem.

Saudi Venture Capital Company (SVC) is a government-backed venture capital firm established in 2018 to boost the growth of startups and SMEs in Saudi Arabia. SVC operates under the umbrella of Monsha'at, the Small and Medium Enterprises General Authority, as part of the country's Financial Sector Development Program. The firm has SAR 2.8 billion ($750 million) in assets under management, aimed at minimizing the funding gaps for emerging businesses by investing in venture capital and private equity funds, as well as co-investing with angel groups. SVC's strategy focuses on stimulating the Saudi venture capital ecosystem by making investments across various sectors, including fintech, e-commerce, and technology. They target companies at all stages, from pre-seed to pre-IPO, playing a critical role in developing the Kingdom's entrepreneurial landscape. Notable investments include contributions to both local and regional funds, which have supported over 700 startups. Led by CEO Dr. Nabeel Koshak, SVC also partners with local and international VC firms, continuously scaling its network and resources. Its mission is to empower high-growth companies to flourish by offering flexible capital, helping Saudi Arabia become a leading player in the MENA venture capital market. SVC remains integral in supporting the country's Vision 2030, fostering innovation and entrepreneurship.

Scale Venture Partners is a leading venture capital firm that invests in early-stage technology companies, particularly those leveraging AI, SaaS, fintech, and security solutions. Based in Foster City, California, Scale typically leads Series A or B rounds, helping startups transition from founder-led growth to scalable, go-to-market machines. Their portfolio includes prominent companies like HubSpot, JFrog, and Papaya Global, which demonstrate their focus on transformative business software across various sectors. Scale Venture Partners takes an active role in its portfolio companies, often serving on boards and providing tailored support through its Scaling Platform, which offers access to executive networks, go-to-market strategies, and benchmarking tools. Their strategic focus on emerging technologies allows them to identify and nurture companies poised for category leadership in areas such as infrastructure, AI, and productivity. With over $2.8 billion in assets under management and a $900 million fund raised in 2022, Scale continues to back high-growth startups across North America, Europe, and Israel. They aim to support companies all the way to IPO, offering deep industry insights and operational expertise. Founders looking for strategic backing to scale their enterprises find a valuable partner in Scale Venture Partners.

Science Angel Syndicate, founded in 2021 and based in Bristol, UK, is an angel investment group focused on early-stage scientific startups. The syndicate brings together a community of entrepreneurs and investors dedicated to backing groundbreaking scientific discoveries that have the potential to make a significant societal impact. With a focus on disruptive technologies at the intersection of biology, chemistry, physics, and computer science, the group is particularly interested in companies that align with the emerging Industry 5.0, where human intelligence is enhanced by cognitive computing and automation. Science Angel Syndicate has made 15 investments across various sectors, including biotechnology, drug discovery, and healthcare devices, with companies like MitoRx Therapeutics and Neuronostics being part of their portfolio. The syndicate supports startups that aim to address critical challenges related to health and the environment, providing not only capital but also access to a network of experts across scientific and commercial domains. The syndicate's unique approach involves leveraging the collective knowledge and experience of its members to thoroughly assess the potential of frontier scientific companies. This collaborative method ensures that investments are made in technologies that are not only innovative but also commercially viable and scalable.

Science Creates is a Bristol-based deep tech ecosystem designed to support scientists and engineers in transforming their ideas into impactful businesses. Founded in partnership with the University of Bristol, Science Creates provides specialized incubator facilities, a network of strategic partners, and a dedicated venture capital fund to accelerate the growth of deep tech startups. The ecosystem comprises two state-of-the-art incubators in central Bristol, offering 45,000 square feet of laboratory, office, and event space. These facilities are specifically designed to cater to the unique needs of deep tech companies, particularly those in biotechnology, materials science, and other advanced technologies. The incubators support startups from the very early stages through to scaling up, providing access to crucial resources such as mentoring, specialized equipment, and industry connections. In addition to the physical infrastructure, Science Creates also manages Science Creates Ventures, a venture capital arm that invests in early-stage deep tech companies. The fund focuses on pre-seed to Series A investments, supporting innovations that have the potential to address significant global challenges in health, energy, and the environment.

SciFi VC is an early-stage venture capital firm founded by Max and Nellie Levchin, focusing on fintech, marketplaces, and scientific breakthroughs. The firm partners with founders who display intense curiosity and intellectual depth, addressing hard problems that often require innovative and science-driven solutions. SciFi VC supports startups from the brainstorming stage, helping define product and strategy before leading the seed round. They bring deep domain expertise and intellectual rigor to early-stage investments, offering strategic support through critical product, strategy, and fundraising decisions. Notable investments include Brex and Loft, with SciFi VC providing essential support in areas such as fundraising, partnerships, and operational advice. The firm also makes opportunistic investments in later-stage companies showing exceptional growth, ensuring long-term partnership and value creation. By emphasizing technology's role in creating next-generation financial products, digital marketplaces, and commercializing scientific advancements, SciFi VC aims to turn science fiction into reality and foster high-impact ventures.

SciFounders is a venture capital firm established in 2021 and based in San Francisco, California. The firm specializes in supporting early-stage, highly technical startups, particularly those operating in the biotech, diagnostics, drug delivery, and deep tech sectors. SciFounders is unique in its approach, focusing on the idea stage, pre-seed, and seed investments, which allows it to engage with companies at the earliest stages of their development. One of the standout features of SciFounders is its SciFounder Fellowship program. This mentorship initiative is designed to support idea-stage founders by providing them with up to $400,000 in investment, along with guidance from a network of experienced entrepreneurs and scientists who have a proven track record in building impactful technologies. The fellowship aims to help founders navigate the complex journey from scientific innovation to commercial success. The leadership team at SciFounders brings deep expertise from both the scientific and entrepreneurial worlds. Notable team members include Matt Krisiloff, previously the director of Y Combinator Research and a founding team member of OpenAI, and Lucas Harrington, co-founder of Mammoth Biosciences, a company known for its pioneering work in CRISPR technology. SciFounders is committed to empowering scientists and technical founders to bring their groundbreaking ideas to life, providing both the financial backing and the mentorship necessary to turn innovative concepts into successful companies.

Scottish Equity Partners (SEP) is a prominent European growth equity investor that focuses on scaling fast-growing technology companies. Founded in 2000 and headquartered in Glasgow, Scotland, SEP has a strong presence in both the UK and internationally, with offices in London and strong connections across Europe and the US. SEP's portfolio includes notable companies like Skyscanner, which grew significantly under SEP’s investment, expanding from a small flight search business into a major global online travel brand before its acquisition by Trip.com for £1.5 billion in 2016. Another standout is Babbel, an online language learning app that became a market leader with over 10 million active subscribers, facilitated by SEP’s support in scaling internationally and strengthening its executive team. The firm typically invests in enterprise software and technology scaleups, with recent investments in companies such as Braincube, Cora Systems, and Pelion. SEP takes a hands-on approach, providing not only capital but also strategic guidance, leveraging their extensive network to help companies achieve sustainable growth. SEP’s team includes experienced partners like Calum Paterson and Stuart Paterson, who play active roles in their portfolio companies, ensuring that the companies have the necessary resources and guidance to succeed.

Scribble Ventures, founded in 2020 and based in Portola Valley, California, is an early-stage venture capital firm that focuses on pre-seed through Series A investments. The firm has a diverse portfolio spanning sectors like information technology, healthcare, software as a service, and consumer products. Notable investments include Whatnot, a platform for live video auctions, Synctera, which provides banking-as-a-service solutions, TrueNorth, a company focused on transforming trucker management, and WellTheory, which offers a membership-based approach to chronic care management. Scribble Ventures is led by Elizabeth Weil, who brings extensive experience from her tenure at OpenAI, Twitter, and Andreessen Horowitz. Scribble Ventures emphasizes a founder-first culture, providing not just capital but also strategic guidance and leveraging their extensive network to support portfolio companies. This support ranges from key introductions to aiding in product development and market strategies. The firm has made 130 investments to date and has seen several successful exits, including Run The World and Welcome.

SCVC is a Bristol-based early-stage venture capital firm that focuses on deep tech startups. It was co-founded in 2020 by Dr. Harry Destecroix and Jon Craton, both successful entrepreneurs with backgrounds in biotech and technology. SCVC is the venture arm of the Science Creates ecosystem, which supports innovative tech startups emerging from research institutions. The firm primarily invests in pre-seed and seed-stage startups, with typical investment sizes ranging from $500,000 to $3 million, and follow-on funding of up to $7 million for high-performing companies. SCVC is particularly focused on advanced technologies that improve human health and the environment, including biotech, quantum tech, AI, and semiconductors. Notable portfolio companies include VyperCore, a RISC-V processor company, Delta g, which develops quantum gravity sensors, and Scarlet Therapeutics, which pioneers red blood cell-based therapies. SCVC's mission is to support deep tech founders by offering not just capital but also hands-on expertise to turn their scientific breakthroughs into commercial ventures. With its second fund targeting $100 million, SCVC is expanding its efforts to back high-impact startups that are leading what they believe to be the next major industrial revolution​.

SEAVI Advent Private Equity, founded in 1984, is a pioneering venture capital and private equity firm in Southeast Asia. Established by industry pioneer Peter A. Brooke, SEAVI Advent operates as the Asian affiliate of Advent International Corporation, one of the world's largest private equity firms headquartered in Boston. SEAVI Advent focuses on investments in business services, specialty retailing, environmental engineering, telecoms, IT, healthcare services, and clean tech sectors. The firm prefers investing in companies based in the Asia Pacific region, with a notable portfolio that includes investments in companies like Weimob, Xuanwu Technology, and Jianzhi Education. The firm is headquartered in Singapore and managed by a team of experienced professionals including Derrick Lee, CEO and Managing Partner, and Boon Kwee Hoe, CFO and Partner. SEAVI Advent has a track record of successful investments and exits, contributing significantly to the growth and development of companies within its portfolio.

SeaX Ventures is a globally focused venture capital firm investing in early-stage companies working on "exponential" technologies that have the potential to transform industries and societies. With a strong emphasis on sectors such as Web3, biotechnology, artificial intelligence, material science, and robotics, SeaX Ventures actively supports visionary founders from around the world, helping them scale their groundbreaking innovations. The firm is known for its unique "3As" strategy: Access, Accelerate, and Advantage. Through their vast corporate network, which spans across Southeast Asia and the U.S., SeaX Ventures provides startups with valuable connections, leveraging the expertise of its sister company, RISE, which boasts over 2,000 startup alumni. SeaX Ventures has raised $60 million in its second fund and partners with large multinational corporations, especially from Southeast Asia, to bridge the gap between Silicon Valley and Asian markets. The firm's portfolio includes innovative companies such as Solana, Verdant Robotics, and Qvin, focusing on high-impact technologies. Their approach is to work closely with founders who are committed to transforming their industries, providing both strategic guidance and growth capital. Founded by experienced venture capitalists and entrepreneurs, SeaX Ventures is deeply involved in helping its portfolio companies reach their full potential by providing global market access and business development support. Their mission is to foster the next generation of transformative companies with a particular focus on deep tech that can drive significant economic and social progress.

SEB Group, headquartered in Stockholm, Sweden, is a leading financial services group with a rich history dating back to 1856. The company has established itself as a major player in corporate and investment banking, particularly in northern Europe, while also offering extensive retail banking services in Sweden and the Baltics. SEB's business strategy, outlined in its 2030 Strategy and the three-year business plan for 2022–2024, focuses on accelerating efforts, strategic change, strategic partnerships, and efficiency improvements. These initiatives aim to future-proof the bank by aligning with technological advancements, sustainability goals, and evolving customer needs. In sustainability, SEB is committed to significant reductions in fossil fuel credit exposure, aiming for a 45-60% reduction by 2030 compared to 2019 levels. By the end of 2023, they had already achieved a 39% reduction. Additionally, through SEB Greentech Venture Capital, the bank has increased its investments in green technology solutions by 239% since 2021, focusing on sectors like renewable energy, water management, and circular economy models. SEB is also heavily involved in sustainable finance. In 2023, it facilitated the issuance of SEK 111 billion in global sustainability and sustainability-linked bonds and increased the volume of green mortgages by 119%, amounting to SEK 17.3 billion. The bank's long-term financial targets include maintaining a strong balance sheet, competitive return on equity, and a high Common Equity Tier 1 capital ratio. SEB's dedication to sustainability is further evidenced by its involvement in the Net-Zero Asset Managers initiative, committing to achieving net-zero greenhouse gas emissions for all assets under management by 2040. The bank also engages extensively in corporate governance, with SEB Investment Management AB conducting over 2,800 dialogues on sustainability and governance issues in 2023.

Second Century Ventures is a leading venture capital fund focused on innovation within the real estate sector. Backed by the National Association of REALTORS® (NAR), SCV leverages its vast network to support the growth of its portfolio companies. Notable investments include DocuSign, Adwerx, and Lulafit, showcasing SCV's commitment to transformative real estate technologies. SCV primarily invests in early to mid-stage companies with a focus on SaaS, big data, digital media, fintech, and business services. Their strategic approach includes a round-agnostic policy, targeting companies with strong market traction and proven product-market fit. They operate globally, with significant investments across the U.S., Canada, Europe, and Asia. SCV's unique value proposition lies in its comprehensive support system, which goes beyond financial backing to include strategic counsel and access to NAR's extensive resources. This support is exemplified by their REACH growth accelerator, designed to help startups scale within the real estate vertical. REACH has expanded internationally, with programs in Australia, Canada, and the UK. The team is led by Managing Director Mark Birschbach, who brings extensive experience from his previous roles in real estate tech startups and investment banking, and Managing Partner Dave Garland, known for his strategic advisory expertise in real estate. They are headquartered in Chicago, Illinois, with additional operations in Silicon Valley. For startups, SCV values strong teams and innovative technologies. They prefer direct introductions or well-prepared executive summaries and investor presentations to initiate contact, emphasizing their long-term commitment to fostering industry growth and technological advancement.

Section 32 is a venture capital firm founded by Bill Maris, the former CEO of Google Ventures. Established in 2017, the firm is based in San Diego, California, and manages approximately $1 billion in assets. Section 32 focuses on early and growth-stage investments across technology, biotechnology, healthcare, and life sciences sectors. The firm has raised multiple funds, including a $160 million inaugural fund and a $200 million second fund. Section 32's portfolio includes notable companies such as Coinbase, CrowdStrike, Thrive Earlier Detection, and Vir Biotechnology. The firm emphasizes investing in transformative technologies that can make a significant impact on the healthcare and tech industries. The team at Section 32 includes several seasoned professionals, such as Michael Pellini, former CEO of Foundation Medicine, who joined as a Managing Partner, and Steve Kafka, former President and COO of Foundation Medicine, who also serves as a Managing Partner. The firm prides itself on a strategic approach that combines deep industry expertise with a commitment to fostering innovation and growth in its portfolio companies.

Seed Capital, a premier venture capital firm based in Denmark, specializes in early-stage investments, particularly focusing on Danish startups or those with strong ties to Denmark. Established in 2004, Seed Capital has played a significant role in nurturing some of the most successful startups in the region. Their notable investments include Vivino, Lunar, Templafy, and Trustpilot, showcasing their broad sector expertise ranging from fintech to consumer internet and enterprise software. Seed Capital's investment strategy revolves around leading seed and Series A rounds with check sizes typically ranging from €2 million to €4 million, but they also maintain substantial reserves for follow-on investments to support companies through their growth stages. Seed Capital's approach is highly hands-on, providing portfolio companies with strategic support and access to a vast network of industry contacts. This includes operational assistance, business development, and guidance on subsequent funding rounds. The firm's commitment to long-term partnerships and deep engagement with founders has been a cornerstone of their success. The investment team, led by Managing Partners Lars Andersen and Ulla Brockenhuus-Schack, boasts a wealth of experience in scaling startups and driving value creation. With a gender-diverse team, Seed Capital emphasizes inclusive growth and leverages a collaborative approach to foster innovation within its portfolio.

Seedcamp is a leading early-stage venture capital firm in Europe, with a focus on backing ambitious founders building disruptive technology across various sectors. Founded in 2007, Seedcamp has a portfolio of over 460 companies, including high-profile successes like Revolut, UiPath, and Wise. Several of its investments have grown into unicorns, and two companies have gone public. The firm is sector-agnostic, investing in areas such as fintech, artificial intelligence, healthtech, and cybersecurity. Seedcamp typically invests early, providing first checks of up to $1 million in Angel and Seed rounds. Their approach combines the agility of an angel investor with the resources and operational support of a seasoned VC. Through their extensive network, including the Seedcamp Expert Collective (SxC), founders gain access to top operators from companies like Uber, Stripe, and Cloudflare, who offer guidance and mentorship to help startups scale quickly. Seedcamp is deeply embedded in Europe’s tech ecosystem, continually launching initiatives like Seedsummit to support early-stage founders with legal and operational advice. With their latest $180M Fund VI, they are well-positioned to lead the next decade of European tech growth​.

SEEDRA Ventures is an early-stage venture capital firm based in Riyadh, Saudi Arabia, focused on fostering innovation and supporting disruptive technologies across various sectors in the region. Established with a mission to accelerate the growth of startups, SEEDRA provides both pre-seed and early-stage funding, helping entrepreneurs bring their ideas to life. The firm takes a hands-on approach, offering more than just capital. SEEDRA actively partners with its portfolio companies, providing technical expertise, mentorship, and access to an extensive network of industry professionals and strategic partners. Their focus spans multiple industries, including tech, retail, industrials, and financial services. SEEDRA Ventures also emphasizes scalability, offering guidance on building internal teams, navigating regulatory challenges, and developing go-to-market strategies. Their robust advisory network ensures that founders are well-supported as they tackle the challenges of growth. Moreover, the firm provides back-office support, recruitment services, and access to tools like AWS and Salesforce, which are critical for scaling startups. By focusing on cultivating the next generation of regional businesses, SEEDRA Ventures plays a vital role in driving the entrepreneurial ecosystem in Saudi Arabia, aligning with the broader goals of economic transformation under Vision 2030.

SeedtoB Capital, headquartered in Atlanta, GA, is a venture capital firm focused on early-stage investments in the healthcare technology sector. Founded by serial entrepreneurs Ritesh Sharma and Shantanu Nigam, who previously co-founded Jvion—a leading clinical AI platform—SeedtoB is dedicated to supporting innovative startups that integrate advanced technology with clinical expertise. Their mission is to help these startups navigate the complex healthcare landscape and successfully transition from Seed to Series B funding. SeedtoB typically invests between $500,000 and $1.5 million in U.S.-based healthcare technology companies. They focus on startups that demonstrate early product-market fit, particularly those generating $500,000 or more in annual recurring revenue. The firm is especially interested in scalable business models that leverage AI to deliver significant clinical and community impact. SeedtoB is also committed to fostering diversity by actively seeking to invest in companies led by underrepresented founders. The firm's portfolio includes companies like Biotia, which uses AI and next-generation sequencing for rapid infectious disease detection, and Mployer Advisor, a platform transforming how employers evaluate and select insurance brokers. SeedtoB’s deep industry experience, particularly in healthcare AI, enables them to provide hands-on support to their portfolio companies, helping them overcome challenges and scale effectively. With a strong focus on innovation and impact, SeedtoB Capital is poised to drive significant advancements in healthcare technology, supporting entrepreneurs who are transforming the industry.

Selva Ventures, founded in 2019, is an early-stage venture capital firm based in Los Angeles that specializes in health and wellness consumer brands. With a mission to make healthier living more accessible, affordable, and enjoyable, Selva Ventures invests primarily in seed and Series A startups with less than $10 million in sales. The firm has a strong emphasis on categories such as food and beverage, personal care, beauty, and wellness, with a growing interest in the beauty and personal care sectors due to their high margins and repeat purchase potential. Selva Ventures is known for its hands-on approach, providing not only capital but also strategic resources and emotional support to its portfolio companies. Notable investments include brands like MUD\WTR, a functional coffee alternative, and Surely, a non-alcoholic wine, both of which align with the firm’s focus on innovative products that resonate emotionally with consumers. The firm’s portfolio is also notable for its diversity, with over 50% of companies led by female or minority founders. Under the leadership of Kiva Dickinson, Selva Ventures uses a proprietary "5M" framework—focusing on Megatrend, Matter, Management, Momentum, and Market—to evaluate potential investments objectively. This approach has helped the firm establish strong relationships within the consumer goods community, including partnerships with industry giants like Unilever Ventures​.